Eli Avisar
- Oncology top 2%
- Cutaneous Melanoma Detection and Management 10
- Global Cancer Incidence and Screening 7
- Lymphatic System and Diseases 5
- Hepatology top 2%
- Cancer Research top 5%
- Breast Cancer Treatment Studies 33
-
- Breast Lesions and Carcinomas 16
- Dermatology top 2%
- Cancer and Skin Lesions 7
-
- Breast Implant and Reconstruction 17
-
- Nonmelanoma Skin Cancer Studies 6
- Co-authors
- Salomone Di SaverioJuan C. GutierrezD. CastaingF KunstlingerS. GiachettiFrançis LéviRené AdamDaniel Azoulay
- Cited by
- OncologyHepatologyCancer Research
- Journals
- Annals of Surgical Oncology (10 papers)Breast Cancer Research and Treatment (7 papers)Cancer Research (5 papers)
- Partner nations
- United StatesIsraelSweden
In The Last Decade
Eli Avisar
65 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 108
- Oncology 1.4k
- Hepatology 385
- Cancer Research 567
- Pathology and Forensic Medicine 454
- Dermatology 183
Countries citing papers authored by Eli Avisar
This map shows the geographic impact of Eli Avisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Avisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Avisar more than expected).
Fields of papers citing papers by Eli Avisar
This network shows the impact of papers produced by Eli Avisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Avisar. The network helps show where Eli Avisar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eli Avisar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 1 | |
| 4 | 2022 | 13 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 14 | |
| 10 | 2020 | 12 | |
| 11 | 2017 | 21 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 4 | |
| 14 | 2015 | 21 | |
| 15 | 2015 | 80 | |
| 16 | 2013 | 161 | |
| 17 | 2011 | 4 | |
| 18 | 2009 | 66 | |
| 19 | 2008 | 35 | |
| 20 | 2007 | 90 |
About Eli Avisar
Eli Avisar is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Dermatology and Surgery, having authored 72 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (33 papers), Breast Implant and Reconstruction (17 papers), Breast Lesions and Carcinomas (16 papers), Cutaneous Melanoma Detection and Management (10 papers), Global Cancer Incidence and Screening (7 papers), Cancer and Skin Lesions (7 papers), Nonmelanoma Skin Cancer Studies (6 papers) and Lymphatic System and Diseases (5 papers). The work is most often cited by research in Oncology (1.4k citations), Hepatology (385 citations), Cancer Research (567 citations), Pathology and Forensic Medicine (454 citations) and Dermatology (183 citations). Eli Avisar has collaborated with scholars based in United States, Israel and Sweden. Frequent co-authors include Salomone Di Saverio, Juan C. Gutierrez, D. Castaing, F Kunstlinger, S. Giachetti, Françis Lévi, René Adam, Daniel Azoulay, Arié Ariche and Stefan Glück. Their work appears in journals such as Annals of Surgical Oncology, Breast Cancer Research and Treatment, Cancer Research, Journal of Clinical Oncology and The American Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.